GVR Report cover Medical Foods Market Size, Share & Trends Report

Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration, By Product (Powder, Pills, Liquid, Other), By Application, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-419-2
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Medical Foods Market Size & Trends

The global medical foods market size was valued at USD 23.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.1% 2024 to 2030. The market growth is driven by the rising prevalence of chronic diseases like Alzheimer's, ADHD, osteoporosis, osteoarthritis, and central nervous system disorders. Noncommunicable diseases, causing 74% of annual deaths (41 million), prompt global action. The UN's 2030 Agenda aims to reduce noncommunicable disease-related deaths by one-third between ages 30 and 70. Amino acid-based enteral nutrition is applied for conditions like sleep disorders, depression, osteoporosis, fibromyalgia, and PTSD. It's tailored for patients with impaired digestive capacity or specific nutrient needs.

U.S. Medical Foods market size and growth rate, 2024 - 2030

Furthermore, the rise in consuming disease-specific formulas is set to boost the market, driven by increasing incidence of targeted diseases and advancements in drug development. Clinical nutrition is increasingly used for personalized treatment, especially in diseases like cancer and cystic fibrosis, where special nutrition is vital to prevent drug interactions. For example, in cystic fibrosis cases, unique digestive enzyme capsules are administered, varying among individuals. Notable companies like Nestlé specialize in personalized clinical nutrition products, offering solutions like Deplin for depression and Metanx for diabetes.

Growing product launches and constant innovations by manufacturers are key factors expected to drive product demand. The need for new food to address inherited metabolic disorders and manage incurable conditions is on the rise. For instance, In July 2022, Danone, as stated in the press release, launched the first-ever dairy and plants blend baby formula in response to parents’ demand for vegetarian & flexitarian options for their babies. The consumption of plant-based products is experiencing significant growth, with over one-third (37%) of EU consumers opting for a vegan, vegetarian, or flexitarian diet. In addition, almost 70% (69%) of parents now prefer their children to consume more plant-based foods.

Industry experts provide insights on the significance of this product launch:

“At Danone, we recognize many parents want to introduce plant-based, vegetarian, and flexitarian options into their baby’s diet, while still meeting their baby’s specific nutritional requirements. Our new Dairy & Plants Blend baby formula has been developed with these needs top of mind.”

-Manuela Borella, Vice President, Global Plant Based Strategy & Business Acceleration, Nutricia's parent company Danone

In October 2020, Nestle Health Science introduced a protein-based ready-to-drink nutritional food in China for special medical purposes, featuring galactomannan to improve gastrointestinal intolerance.

Market Concentration & Characteristics

Market growth is at a high stage, accelerating in pace. The medical foods market, driven by a surge in chronic diseases, exhibits significant innovation. Key players are engaging in industry consolidation through acquisitions, mergers, and partnerships to expand product reach. For example, ByHeart's acquisition of the Allerton facility from DairiConcepts (a DFA subsidiary) in January 2023 tripled supply capacity and fortified formula production in the U.S. The additional domestic infant formula manufacturing facility, along with ByHeart's existing facilities, positions the company to achieve its annual goal of feeding 500,000 babies.

Medical Foods Market Concentration & Characteristics

Industry expert insights-

"Infant formula is one of the most value added dairy products in the world. We at Dairy Farmers of America are committed to producing high-quality milk and dairy ingredients in a sustainable way while building relationships that leverage the value of dairy nutrition for infant formula.

We look forward to continuing to work with ByHeart, which we believe has the potential to unlock significant opportunity for our 11,500 family farmers across the country.”

- Martin Bates, President, Dairy Farmers of America (DFA) Ingredient Solutions

The medical foods market is subject to increasing regulatory scrutiny. According to Federal Food, Drug, and Cosmetic Act, for a product to be classified as medical food, it must be labeled for dietary management of a specific disease condition with discrete nutritional requirements and must be intended for oral or tube feeding. In addition, the product must be intended for use under specific medical supervision.

Threat of substitute product is expected to be low in medical foods market over the forecast period. Medical food are partial or complimentary meal replacement, and these products effectively enhance the chronic disease management.

Growing geriatric population along with the increasing number of chronic diseases would offer growth opportunities for the market over the forecast period. Medical foods products are highly adopted by the geriatric population who are dealing with chronic conditions for proper intake of nourishment and, thus, fueling the market growth.

Route of Administration Insights

Oral segment led the market and accounted for 70.0% of the global revenue in 2023. Increased preference for orally administered products, commercial viability, and supportive initiatives are key factors driving the demand for orally administered medical foods. Furthermore, the growing manufacturing of oral products in the form of prethickened products, powders, and pills is anticipated to fuel the segment. For instance, in January 2023, Nutricia launched its Fortimel PlantBased Energy, a plant-based oral nutritional supplement designed to address the nutritional requirements of individuals facing malnutrition or those at risk due to illness. This addition to the Fortimel portfolio leverages Nutricia's parent company, Danone's proficiency in plant nutrition. It further extends the range of Fortimel products, which are clinically proven medical nutrition solutions specifically developed to cater to the daily needs of patients.

Enteral route of the administration segment is expected to witness the fastest growth over the forecast years. The growing prevalence of cardiovascular and chronic diseases resulting from several metabolic disorders leads to difficulty in oral food consumption and increases the preference for medical food feeding through enteral mode. Moreover, the growing focus of the manufacturers to develop technologically advanced enteral feeding devices is positively impacting the segment growth.

Product Insights

Powder segment accounted for the largest market revenue share in 2023. Medical foods are most widely available in powder form, which can be administered through the oral route or enteral route by mixing with milk or water, as advised by the physician. Medical foods in the powdered formula are suitable for patients of all age groups, especially in the oral route. Owing to a high preference for powdered formulations due to ease of consumption, manufacturers are developing product categories in line with consumer preferences. For instance, in January 2022, Danone launched Souvenaid, a powder version of a medical nutrition drink to support memory function in the early stages of Alzheimer's disease.

The liquid segment is anticipated to grow at the fastest rate during the forecast period owing to the rising adoption of liquid formulations in the pediatric and geriatric population, where the intake of solid formulations is limited or impossible and in case of clinically diagnosed dysphagia or when oral physiology is limited. In addition, the ease of administration of liquid-based medical foods and the commercial viability of these products will drive the segment. Increasing functional gastrointestinal disorders and the recommendation of doctors to intake liquid formulated medical food who suffer from these illnesses before or after surgeries support the segment growth. Moreover, the increasing benefits of taking liquid formulated food to maintain sufficient hydration and electrolyte balance favor the segment growth.

Application Insights

The cancer application segment dominated the market in 2023. According to the Pan America Health Organization, North America saw approximately 4 million new cancer diagnoses in 2020, resulting in 1.4 million deaths. Notably, 57% of new cases and 47% of related deaths affected individuals aged 69 or younger. Globally, 2020 recorded an estimated 20 million new cancer cases and 10 million deaths. Projections indicate a 60% increase in the cancer burden over the next two decades, reaching approximately 30 million new cases by 2040, with significant rises in low- and middle-income countries. These statistics underscore the increasing for comprehensive strategies to address the growing cancer burden and support affected populations worldwide.

Cancer weakens immunity, leading to malnutrition in 40% to 80% of cases. Medical food administration is an effective option for restoring nutritional balance in malnourished patients. Consequently, the demand for medical foods in cancer treatments is expected to rise over the forecast period.

Sales Channel Insights

Institutional sales channel held the largest market share in 2023. The growing number of patient visits to the hospitals and other healthcare facilities for the diagnosis and treatment of several chronic and dietary disorders is driving the segment. Medical foods are prescribed by doctors for particular disease management. In addition, the increasing preference among the patients to consult a doctor in the hospitals for their chronic disease management will drive the segment. Moreover, the growing number of private and public healthcare institutions and the increasing chronic disease patient population across the globe will support the segment growth.

Global Medical Foods market share and size, 2023

The online sales segment is anticipated to expand at the fastest rate over the forecast period. Preference for the online purchase of medical foods is rising owing to the convenience offered by this sales channel. Although medical foods are mainly consumed under medical surveillance, these are intended for long-term nutrition management, which is resulting in surging sales through e-commerce. Thus, with the e-commerce penetration, there is a shift from traditional methods of purchase to online purchase of medical foods, thereby offering various market growth opportunities.

Regional Insights

North America dominated the market and accounted for 29.7% share in 2023. Growth in the market can be attributed to the increasing geriatric population, which is more susceptible to chronic diseases, such as gastrointestinal disorders, metabolic disorders, and neurological disorders. According to the United Health Foundation, in 2022, about 17.3% of the population in the U.S. was aged 65 and above. Furthermore, around 56 million elderly people are expected to depend on medical foods to fulfill their nutritional needs in the U.S. by 2030. Moreover, the growing number of premature infants in critical care is a major factor driving market growth. For instance, in 2022, CDC reported that approximately 10% of infants born in the U.S. were affected by preterm birth. In addition, the preterm birth rate decreased by 1% in 2022, after a 4% increase from 2020 to 2021. These aforementioned factors are anticipated to fuel market growth over the forecast period.

Medical Foods Market Trends, by Region, 2024 - 2030

The Asia Pacific region is anticipated to be the fastest-growing regional market over the forecast period owing to the increasing rate of cancer and diabetic patients, along with several government initiatives in the healthcare segment. In addition, the local presence of key players and untapped opportunities provided by the region are among the major factors propelling the regional market growth.

Key Companies & Market Share Insights

Some of the key players operating in the market include Danone, Nestlé, Fresenius Kabi AG and Abbott. Furthermore, Key innovators in the market are utilizing strategies like new product launches to enhance their market presence.

For instance:

  • Lanfam LLC

    • In March 2022, the company launched a new medical food Proleeva for chronic pain relief conditions such as inflammatory disorders including fibromyalgia, osteoporosis, diabetic neuropathy, and rheumatoid arthritism. The company also offering customized solutions for specific condition which help the company recognize as an innovator in the market)

  • SFI Health

    • In December 2021, the company introduced two new medical foods, EQUAZEN PRO and Ther-Biotic PRO IBS Relief, for treating Irritable Bowel Syndrome (IBS) and supporting dietary nutrition. These innovations have contributed to the company's market position as key innovators.)

Notable Product-Level Data for Key Companies at the Application Level

Companies

Top Notable Products/Brands

Available Product Form

Application

Market Presence

Danone

Aptamil

Powder/Liquid

Constipation Relief

High

Nutrison

Liquid/Semi-elemental

Malabsorption

High to Medium

Alzheimer's

Cancer

Cerebral Plasy

Diabetes

Dysphagia

Gastrointestinal Disease

Wound Care

Parkinson's Disease

Multiple Food Allergy

Eosinophilic Esophagatis

Short Bowel Sydrome

Malabsorption

Abbott

Ensure

Powder

Diabetes

High

Glucerna

Shakes/Bars/Powder

Diabetes

High

Similac

Powder/Liquid

Nutritional Deficiency

High to Medium

 

Key Medical Foods Companies:

  • Danone
  • Nestlé
  • Abbott
  • Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
  • Primus Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC

Recent Developments

  • In November 2023, Danone launched its first medical nutrition product, Fortimel, for adults in China, categorized under foods for special medical purposes. This launch is a crucial component of Danone's strategy in China, aimed at utilizing its scientific expertise across all life stages and promoting growth of the adult medical nutrition segment.

  • In September 2023, Danone announced a €50 million (USD 53.78 million) line expansion of its production facility at Opole, Poland, to meet the increasing demand for medical nutrition worldwide. This move aims to enhance its position in the adult medical nutrition market, with the growing rate of chronic diseases and aging population. The expansion is anticipated to enable Danone to serve patients across the globe, as many people are expected to require medical nutrition at some point in their lives due to diseases such as cancer and stroke, which can result in malnutrition.

  • In March 2023, Danone acquired ProMedica, a Poland-based company that specializes in providing care services for patients in their homes. This acquisition is part of Danone's lucrative specialized nutrition market expansion strategy, to strengthen its presence in Poland.

  • In February 2023, Neslte and EraCal Therapeutics entered into a research collaboration to identify novel nutraceuticals relevant to controlling food intake.

Medical Foods Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 24.7 billion

Revenue forecast in 2030

USD 33.4 billion

Growth Rate

CAGR of 5.1% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Route of administration, product, application, sales channel, region

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, Germany, U.K., France, Italy, Spain, Sweden, Denmark, Norway, China, Japan, India, South Korea, Australia, Brazil Mexico, Argentina, Saudi Arabia, UAE, Kuwait, Qatar and South Africa

Key companies profiled

Danone, Nestlé, Abbott, Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company), Primus Pharmaceuticals Inc., Fresenius Kabi AG, Mead Johnson & Company, LLC

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Medical Foods Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medical foods market report based on route of administration, product, application, sales channel, and region.

  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

    • Oral

    • Enteral

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Powder

    • Pills

    • Liquid

    • Other

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Chronic Kidney Disease

    • Minimal Hepatic Encephalopathy

    • Chemotherapy Induced Diarrhoea

    • Pathogen Related Infections

    • Diabetic Neuropathy

    • ADHD

    • Depression

    • Alzheimer's Disease

    • Nutritional Deficiency

    • Orphan Diseases

      • Tyrosinemia

      • Eosinophilic Esophagitis

      • FPIES

      • Phenylketonuria

      • MSUD

      • Homocystinuria

      • Others

    • Wound Healing

    • Chronic Diarrhea

    • Constipation Relief

    • Protein Booster

    • Dysphagia

    • Pain Management

    • Parkinson's Disease

    • Epilepsy

    • Other Cancer related treatments

    • Severe Protein Allergy

    • Cancer

    • Cachexia

    • Other

  • Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

    • Online Sales

    • Retail Sales

    • Institutional Sales

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Sweden

      • Denmark

      • Norway

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa (MEA)

      • Saudi Arabia

      • UAE

      • South Africa

      • Kuwait

      • Qatar

Frequently Asked Questions About This Report

Table of Contents

Chapter 1 Medical Foods Market: Methodology and Scope
                   1.1 Market segmentation and scope
                   1.2 Market definition
                   1.3 Research methodology
                       1.3.1 Information procurement
                       1.3.2 Purchased database
                       1.3.3 GVR's internal database
                       1.3.4 Primary research
                       1.3.5 Research methodology
                       1.3.6 Research scope and assumptions
                       1.3.7 List of secondary sources
                       1.3.8 List of primary sources
Chapter 2 Medical Foods Market: Executive Summary
                   2.1 Market outlook
                       2.1.1 Medical foods market snapshot
                       2.1.2 Medical foods market: Segment snapshot (Part 1)
                       2.1.3 Medical foods market: Segment snapshot (Part 2)
                       2.1.4 Medical foods market: Market dynamics
Chapter 3 Medical Foods Market: Medical Foods Market Variables, Trends & Scope
                   3.1 Market lineage outlook
                       3.1.1 Parent market outlook
                           3.1.1.1 Nutritional supplements market
                       3.1.2 Ancillary market outlook
                           3.1.2.1 Parenteral nutrition market:
                           3.1.2.2 Enteral feeding devices market
                   3.2 Pricing analysis
                   3.3 Industry analysis
                       3.3.1 User perspective analysis
                           3.3.1.1 Consumer behavior analysis
                           3.3.1.2 Market influencer analysis
                       3.3.2 Key end users
                   3.4 Technology outlook
                       3.4.1 Technology timeline
                   3.5 Regulatory framework
                       3.5.1 Reimbursement framework
                           3.5.1.1 North America
                           3.5.1.2 Europe
                           3.5.1.3 Asia Pacific
                       3.5.2 Standards, compliance & safety
                   3.6 Market Dynamics
                       3.6.1 Market Driver Analysis
                           3.6.1.1 Rising geriatric population
                           3.6.1.2 Growing prevalence of chronic diseases
                           3.6.1.3 Shifting trend toward the consumption of disease-specific formulas
                           3.6.1.4 Growing demand for neonatal and preterm enteral feeding
                           3.6.1.5 Rising organizational strategic initiatives To bolster market presence
                       3.6.2 Market Restraint Analysis
                           3.6.2.1 Lack of awareness in the medical community
                           3.6.2.2 Improper categorization of medical foods
                       3.6.3 Industry Challenges and Opportunity
                           3.6.3.1 Complications associated with small-bore connectors
                           3.6.3.2 Risks associated with enteral feeding
                       3.6.4 Industry Opportunity Overview
                   3.7 Medical Foods Market Analysis Tools
                       3.7.1 Medical Foods Market - PESTLE Analysis
                       3.7.2 Industry Analysis - Porter’s
                   3.8 Major Deals & Strategic Alliances Analysis
                       3.8.1 Mergers & Acquisitions
                       3.8.2 Market Entry Strategies
                       3.8.3 Product Recalls
                   3.9 Impact of COVID-19 on Medical Foods Market
Chapter 4 Medical Foods Market: Route of Administration Estimates & Trend Analysis
                   4.1 Medical Foods Market: Route of Administration Movement Analysis, 2023 & 2030 (USD Million)
                   4.2 Oral
                       4.2.1 Oral Medical foods market estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.3 Enteral
                       4.3.1 Enteral Medical foods market estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Medical Foods Market: Product Estimates & Trend Analysis
                   5.1 Medical Foods Market: Product Movement Analysis, 2023 & 2030 (USD Million)
                   5.2 Overview and Guidelines about Packaging of Different Products
                   5.3 Pills
                       5.3.1 Medical foods market estimates and forecasts for pills formulation, 2018 - 2030 (USD Million)
                   5.4 Powder
                       5.4.1 Medical foods market estimates and forecasts for powder formulation, 2018 - 2030 (USD Million)
                   5.5 Liquid
                       5.5.1 Medical foods market estimates and forecasts for liquid formulation, 2018 - 2030 (USD Million)
                   5.6 Others
                       5.6.1 Medical foods market estimates and forecasts for other formulations, 2018 - 2030 (USD Million)
Chapter 6 Medical Foods Market: Application Estimates & Trend Analysis
                   6.1 Medical Foods Market: Application Movement Analysis, 2023 & 2030 (USD Million)
                   6.2 Chronic Kidney Diseases
                       6.2.1 Medical foods market estimates and forecasts for chronic kidney diseases, 2018 - 2030 (USD Million)
                   6.3 Minimal Hepatic Encephalopathy
                       6.3.1 Medical foods market estimates and forecasts for minimal hepatic encephalopathy, 2018 - 2030 (USD Million)
                   6.4 Chemotherapy Induced Diarrhea
                       6.4.1 Medical foods market estimates and forecasts for chemotherapy induced diarrhea, 2018 - 2030 (USD Million)
                   6.5 Pathogen Related Infection
                       6.5.1 Medical foods market estimates and forecasts for pathogen related infections, 2018 - 2030 (USD Million)
                   6.6 Diabetic Neuropathy
                       6.6.1 Medical foods market estimates and forecasts for diabetic neuropathy, 2018 - 2030 (USD Million)
                   6.7 ADHD
                       6.7.1 Medical foods market estimates and forecasts for ADHD, 2018 - 2030 (USD Million)
                   6.8 Depression
                       6.8.1 Medical foods market estimates and forecasts for depression, 2018 - 2030 (USD Million)
                   6.9 Alzheimer's Disease
                       6.9.1 Medical foods market estimates and forecasts for Alzheimer's disease, 2018 - 2030 (USD Million)
                   6.10 Nutritional Deficiency
                       6.10.1 Medical Foods Market Estimates and Forecasts for nutritional deficiency, 2018 - 2030 (USD Million)
                   6.11 Orphan Diseases
                       6.11.1 Medical Foods Market Estimates and Forecasts for orphan diseases, 2018 - 2030 (USD Million)
                       6.11.2 Phenylketonuria
                           6.11.2.1 Medical foods market estimates and forecasts for phenylketonuria, 2018 - 2030 (USD Million)
                       6.11.3 Eosinophilic Esophagitis
                           6.11.3.1 Medical foods market estimates and forecasts for eosinophilic esophagitis, 2018 - 2030 (USD Million)
                       6.11.4 Food protein-induced enterocolitis syndrome
                           6.11.4.1 Medical foods market estimates and forecasts for FPIES, 2018 - 2030 (USD Million)
                       6.11.5 TYROSINEMIA
                           6.11.5.1 Medical foods market estimates and forecasts for tyrosinemia, 2018 - 2030 (USD Million)
                       6.11.6 Maple Syrup Urine Disease
                           6.11.6.1 Medical foods market estimates and forecasts for MSUD, 2018 - 2030 (USD Million)
                       6.11.7 HOMOCYSTINURIA
                           6.11.7.1 Medical foods market estimates and forecasts for homocystinuria, 2018 - 2030 (USD Million)
                       6.11.8 Other Orphan Diseases
                           6.11.8.1 Medical foods market estimates and forecasts for other orphan diseases, 2018 - 2030 (USD Million)
                   6.12 Wound Healing
                       6.12.1 Medical foods market estimates and forecasts for wound healing, 2018 - 2030 (USD Million)
                   6.13 Chronic Diarrhea
                       6.13.1 Medical foods market estimates and forecasts for chronic diarrhea, 2018 - 2030 (USD Million)
                   6.14 Constipation Relief
                       6.14.1 Medical foods market estimates and forecasts for constipation relief, 2018 - 2030 (USD Million)
                   6.15 Protein Booster
                       6.15.1 Medical foods market estimates and forecasts for protein booster, 2018 - 2030 (USD Million)
                   6.16 Dysphagia
                       6.16.1 Medical foods market estimates and forecasts for dysphagia, 2018 - 2030 (USD Million)
                   6.17 Pain Management
                       6.17.1 Medical foods market estimates and forecasts for pain management, 2018 - 2030 (USD Million)
                   6.18 Parkinson's Disease
                       6.18.1 Medical foods market estimates and forecasts for Parkinson's disease, 2018 - 2030 (USD Million)
                   6.19 Epilepsy
                       6.19.1 Medical foods market estimates and forecasts for epilepsy, 2018 - 2030 (USD Million)
                   6.20 Cancer
                       6.20.1 Medical foods market estimates and forecasts for cancer, 2018 - 2030 (USD Million)
                   6.21 Cachexia
                       6.21.1 Medical foods market estimates and forecasts for Cachexia, 2018 - 2030 (USD Million)
                   6.22 Severe Protein Allergy
                       6.22.1 Medical foods market estimates and forecasts for severe protein allergy, 2018 - 2030 (USD Million)
                   6.23 Other Diseases
                       6.23.1 Medical foods market estimates and forecasts for other diseases, 2018 - 2030 (USD Million)
Chapter 7 Medical Foods Market: Sales Channel Estimates & Trend Analysis
                   7.1 Medical Foods Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
                   7.2 Online Sales
                       7.2.1 Medical foods market estimates and forecasts for online sales channel, 2018 - 2030 (USD Million)
                   7.3 Retail Sales
                       7.3.1 Medical foods market estimates and forecasts for retail sales channel, 2018 - 2030 (USD Million)
                   7.4 Institutional Sales
                       7.4.1 Medical foods market estimates and forecasts for institutional sales channel, 2018 - 2030 (USD Million)
Chapter 8 Medical Foods Market: Regional Estimates and Trend Analysis
                   8.1 Medical Foods Market: Regional Movement Analysis, 2023 & 2030 (USD Million)
                   8.2 North America
                       8.2.1 North America Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.2.2 U.S.
                           8.2.2.1 Regulatory Scenario
                           8.2.2.2 Country Dynamics
                           8.2.2.3 U.S. Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.2.3 Canada
                           8.2.3.1 Regulatory Scenario
                           8.2.3.2 Country Dynamics
                           8.2.3.3 Canada Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   8.3 Europe
                       8.3.1 Regulatory Framework
                       8.3.2 Europe Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.3 UK
                           8.3.3.1 Regulatory Scenario
                           8.3.3.2 Country Dynamics
                           8.3.3.3 UK Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.4 Germany
                           8.3.4.1 Regulatory Scenario
                           8.3.4.2 Country Dynamics
                           8.3.4.3 Germany Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.5 France
                           8.3.5.1 Regulatory Scenario
                           8.3.5.2 Country Dynamics
                           8.3.5.3 France Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.6 Spain
                           8.3.6.1 Regulatory Scenario
                           8.3.6.2 Country Dynamics
                           8.3.6.3 Spain Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.7 Italy
                           8.3.7.1 Regulatory Scenario
                           8.3.7.2 Country Dynamics
                           8.3.7.3 Italy Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.8 Sweden
                           8.3.8.1 Regulatory Scenario
                           8.3.8.2 Country Dynamics
                           8.3.8.3 Sweden Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.9 Denmark
                           8.3.9.1 Regulatory Scenario
                           8.3.9.2 Country Dynamics
                           8.3.9.3 Denmark Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.3.10 Norway
                           8.3.10.1 Regulatory Scenario
                           8.3.10.2 Country Dynamics
                           8.3.10.3 Norway Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   8.4 Asia Pacific
                       8.4.1 Asia Pacific Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.4.2 Japan
                           8.4.2.1 Regulatory Scenario
                           8.4.2.2 Country Dynamics
                           8.4.2.3 Japan Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.4.3 China
                           8.4.3.1 Regulatory Scenario
                           8.4.3.2 Country Dynamics
                           8.4.3.3 China Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.4.4 Australia
                           8.4.4.1 Regulatory Scenario
                           8.4.4.2 Country Dynamics
                           8.4.4.3 Australia Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.4.5 India
                           8.4.5.1 Regulatory Scenario
                           8.4.5.2 Country Dynamics
                           8.4.5.3 India Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.4.6 South Korea
                           8.4.6.1 Regulatory Scenario
                           8.4.6.2 Country Dynamics
                           8.4.6.3 South Korea Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   8.5 Latin America
                       8.5.1 Latin America Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.5.2 Brazil
                           8.5.2.1 Regulatory Scenario
                           8.5.2.2 Country Dynamics
                           8.5.2.3 Brazil Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.5.3 Mexico
                           8.5.3.1 Regulatory Scenario
                           8.5.3.2 Country Dynamics
                           8.5.3.3 Mexico Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.5.4 Argentina
                           8.5.4.1 Regulatory Scenario
                           8.5.4.2 Country Dynamics
                           8.5.4.3 Argentina Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   8.6 Middle East & Africa (MEA)
                       8.6.1 MEA Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.6.2 South Africa
                           8.6.2.1 Regulatory Scenario
                           8.6.2.2 Country Dynamics
                           8.6.2.3 South Africa Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.6.3 Saudi Arabia
                           8.6.3.1 Country Dynamics
                           8.6.3.2 Saudi Arabia Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.6.4 The United Arab Emirates (UAE)
                           8.6.4.1 Country Dynamics
                           8.6.4.2 UAE Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.6.5 Kuwait
                           8.6.5.1 Country Dynamics
                           8.6.5.2 Kuwait Medical Foods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                       8.6.6 Qatar
                           8.6.6.1 Country Dynamics
                           8.6.6.2 Qatar Medical Foods Market estimates and forecasts, 2018 - 2030 (USD Million)
                       8.6.7 Middle East Regulatory Scenario
Chapter 9 Competitive Analysis
                   9.1 Recent Developments & Impact Analysis, by Key Market Participants
                   9.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                   9.3 Vendor Landscape
                       9.3.1 Key Customers
                       9.3.2 List Of Key Distributors and Channel Partners
                       9.3.3 Key Company Market Share Analysis, 2023
                   9.4 Public Companies
                       9.4.1 Company Market Position Analysis
                       9.4.2 Company Market Ranking By Region
                   9.5 Key Company Insights
                       9.5.1 Abbott
                       9.5.2 Nestle
                       9.5.3 Danone
                   9.6 Notable Product-Level Data for Key Companies at the Application Level
                       9.6.1 Key Analyst Highlights On The Table's Products
Chapter 10 Competitive Landscape
                   10.1 Company Profiles
                       10.1.1 Participants’ Overview
                           10.1.1.1 Danone S.A.
                               10.1.1.1.1 Participant’s Overview
                               10.1.1.1.2 Financial Performance
                               10.1.1.1.3 Product Benchmarking
                               10.1.1.1.4 Recent Developments
                           10.1.1.2 Nestlé S.A.
                               10.1.1.2.1 Participant’s Overview
                               10.1.1.2.2 Financial Performance
                               10.1.1.2.3 Product Benchmarking
                               10.1.1.2.4 Recent Developments
                           10.1.1.3 Abbott
                               10.1.1.3.1 Participant’s Overview
                               10.1.1.3.2 Financial Performance
                               10.1.1.3.3 Product Benchmarking
                               10.1.1.3.4 Recent Developments
                           10.1.1.4 Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
                               10.1.1.4.1 Participant’s Overview
                               10.1.1.4.2 Financial Performance
                               10.1.1.4.3 Product Benchmarking
                               10.1.1.4.4 Recent Developments
                           10.1.1.5 Primus Pharmaceuticals Inc.
                               10.1.1.5.1 Participant’s Overview
                               10.1.1.5.2 Financial Performance
                               10.1.1.5.3 Product Benchmarking
                               10.1.1.5.4 Recent Developments
                           10.1.1.6 Fresenius Kabi AG
                               10.1.1.6.1 Participant’s Overview
                               10.1.1.6.2 Financial Performance
                               10.1.1.6.3 Product Benchmarking
                               10.1.1.6.4 Recent Developments
                           10.1.1.7 Mead Johnson & Company, LLC
                               10.1.1.7.1 Participant’s Overview
                               10.1.1.7.2 Financial Performance
                               10.1.1.7.3 Product Benchmarking
                               10.1.1.7.4 Recent Developments
                       10.1.2 Financial Performance
                           10.1.2.1 Public Market Players
                           10.1.2.2 Private Market Players
                   10.2 Product Benchmarking
                   10.3 Strategy Mapping
                       10.3.1 Acquisition
                       10.3.2 Collaboration
                       10.3.3 Expansions
                       10.3.4 Partnership
                       10.3.5 Product Launch
                       10.3.6 Others
                   10.4 List of Other Companies Providing Medical Foods
                   10.5 Sales Revenue by Online Sales Channel and Retail Sales Channel for Key Companies
                       10.5.1 Nestlé S.A
                           10.5.1.1 Online Sales Channel Insights
                           10.5.1.2 Retail Sales Channel Insights
                       10.5.2 Danone S.A.
                           10.5.2.1 Online Sales Channel Insights
                           10.5.2.2 Retail Sales Channel Insights
                       10.5.3 Abbott
                           10.5.3.1 Online Sales Channel Insights
                           10.5.3.2 Retail Sales Channel Insights 


List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies /technology disruptors/innovators
Table 3 Supplier ranking
Table 4 Few examples of the medical foods in the oral form
Table 5 Few examples of the products available in powder form:
Table 6 Few examples of medical foods in the other formulations
Table 7 Oral medical foods market revenue estimates and forecasts, by products, 2018 - 2030 (USD Million)
Table 8 Enteral medical foods market revenue estimates and forecasts, by products, 2018 - 2030 (USD Million)
Table 9 List of key players, by region
Table 10 North America medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 11 North America medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 North America medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 North America orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 14 North America medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 15 U.S. medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 16 U.S. medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 17 U.S. medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 18 U.S. orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 19 U.S. medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 20 Canada medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 21 Canada medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 22 Canada medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 23 Canada orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 24 Canada medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 25 Europe medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 26 Europe medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 27 Europe medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 28 Europe orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 Europe medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 30 UK medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 31 UK medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 UK medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 33 UK orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 34 UK medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 35 Germany medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 36 Germany medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 37 Germany medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Germany orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 39 Germany medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 40 France medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 41 France medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 42 France medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 43 France orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 44 France medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 45 Spain medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 46 Spain medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 47 Spain medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 48 Spain orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 49 Spain medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 50 Italy medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 51 Italy medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 Italy medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 53 Italy orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 54 Italy medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 55 Denmark medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 56 Denmark medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 57 Denmark medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 58 Denmark orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 59 Denmark medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 60 Norway medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 61 Norway medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 62 Norway medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 63 Norway orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 64 Norway medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 65 Sweden medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 66 Sweden medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 67 Sweden medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 68 Sweden orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Sweden medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 70 Asia Pacific medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 71 Asia Pacific medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 72 Asia Pacific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 73 Asia Pacific orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 74 Asia Pacific medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 75 Japan medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 76 Japan medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 77 Japan medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 78 Japan orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 79 Japan medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 80 China medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 81 China medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 82 China medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 83 China orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 84 China medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 85 Australia medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 86 Australia medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 87 Australia medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 88 Australia orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 89 Australia medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 90 India medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 91 India medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 92 India orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 93 India medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 94 South Korea medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 95 South Korea medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 96 South Korea medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 97 South Korea orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 98 South Korea medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 99 Latin America medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 100 Latin America medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 101 Latin America medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 102 Latin America orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 103 Latin America medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 104 Brazil medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 105 Brazil medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 106 Brazil medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 107 Brazil orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 108 Brazil medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 109 Mexico medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 110 Mexico medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 111 Mexico medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 112 Mexico orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 113 Mexico medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 114 Argentina medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 115 Argentina medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 116 Argentina medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 117 Argentina orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 118 Argentina medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 119 MEA medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 120 MEA medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 121 MEA medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 122 MEA orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 123 MEA medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 124 South Africa medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 125 South Africa medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 126 South Africa medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 127 South Africa orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 128 South Africa medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 129 Saudi Arabia medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 130 Saudi Arabia medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 131 Saudi Arabia medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 134 UAE medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 135 UAE medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 136 UAE medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 137 UAE orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 138 UAE medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 139 Kuwait medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 140 Kuwait medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 141 Kuwait medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 142 Kuwait orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 143 Kuwait medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 144 Qatar medical foods market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 145 Qatar medical foods market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 146 Qatar medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 147 Qatar orphan disease specific medical foods market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 148 Qatar medical foods market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 149 List of other players
Table 150 Participant’s overview
Table 151 Financial performance
Table 152 Key companies undergoing expansions
Table 153 Key companies undergoing acquisitions
Table 154 Key companies undergoing collaborations
Table 155 Key companies launching new components/services
Table 156 Key companies undergoing partnerships
Table 157 Key companies undertaking other strategies


List of Figures

Fig. 1 Medical foods market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Enteral feeding formulas market: Research methodology
Fig. 6 Medical foods market snapshot, 2023, (USD Billion)
Fig. 7 Medical foods market: Segment snapshot, 2023, (USD Billion) (Part 1)
Fig. 8 Medical foods market: Segment snapshot, 2023, (USD Billion) (Part 2)
Fig. 9 Medical foods market: Market dynamics
Fig. 10 Medical foods market trends & outlook
Fig. 11 Parent market analysis, 2023
Fig. 12 Timeline for new ENFit Connectors
Fig. 13 Consumer decision-making process
Fig. 14 Evolution of medical foods
Fig. 15 Market driver analysis (Current & future impact)
Fig. 16 Global population, aged 65 years and above, 2018 - 2023 (Million)
Fig. 17 Increase in the number of people with chronic conditions in the U.S., 1995-2030 (in million)
Fig. 18 Market restraint analysis (current & future impact)
Fig. 19 Medical foods market - PESTLE analysis
Fig. 20 Industry analysis - Porter’s
Fig. 21 Medical foods market, route of administration outlook: Key takeaways, USD Million
Fig. 22 Medical foods market: route of administration movement analysis, 2023 & 2030 (USD Million)
Fig. 23 Oral medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Enteral medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Medical foods market, product outlook: Key takeaways, USD Million
Fig. 26 Medical foods market: Product movement analysis, 2023 & 2030 (USD Million)
Fig. 27 Medical foods market estimates and forecasts for pills formulation, 2018 - 2030 (USD Million)
Fig. 28 Medical foods market estimates and forecasts for powder formulation, 2018 - 2030 (USD Million)
Fig. 29 Medical foods market estimates and forecasts for liquid formulation, 2018 - 2030 (USD Million)
Fig. 30 Medical foods market estimates and forecasts for other formulations, 2018 - 2030 (USD Million)
Fig. 31 Medical foods market, application outlook: Key takeaways, USD Million
Fig. 32 Medical foods market: application movement analysis, 2023 & 2030 (USD Million)
Fig. 33 Medical foods market estimates and forecasts for chronic kidney diseases, 2018 - 2030 (USD Million)
Fig. 34 Medical foods market estimates and forecasts for minimal hepatic encephalopathy, 2018 - 2030 (USD Million)
Fig. 35 Medical foods market estimates and forecasts for chemotherapy induced diarrhea, 2018 - 2030 (USD Million)
Fig. 36 Medical foods market estimates and forecasts for pathogen related infections, 2018 - 2030 (USD Million)
Fig. 37 Medical foods market estimates and forecasts for diabetic neuropathy, 2018 - 2030 (USD Million)
Fig. 38 Medical foods market estimates and forecasts for ADHD, 2018 - 2030 (USD Million)
Fig. 39 Medical foods market estimates and forecasts for depression, 2018 - 2030 (USD Million)
Fig. 40 Medical foods market estimates and forecasts for Alzheimer's disease, 2018 - 2030 (USD Million)
Fig. 41 Medical foods market estimates and forecasts for nutritional deficiency, 2018 - 2030 (USD Million)
Fig. 42 Medical foods market estimates and forecasts for orphan diseases, 2018 - 2030 (USD Million)
Fig. 43 Medical foods market estimates and forecasts for phenylketonuria, 2018 - 2030 (USD Million)
Fig. 44 Medical foods market estimates and forecasts for eosinophilic esophagitis, 2018 - 2030 (USD Million)
Fig. 45 Medical foods market estimates and forecasts for FPIES, 2018 - 2030 (USD Million)
Fig. 46 Medical foods market estimates and forecasts for tyrosinemia, 2018 - 2030 (USD Million)
Fig. 47 Medical foods market estimates and forecasts for MSUD, 2018 - 2030 (USD Million)
Fig. 48 Medical foods market estimates and forecasts for homocystinuria, 2018 - 2030 (USD Million)
Fig. 49 Medical foods market estimates and forecasts for other orphan diseases, 2018 - 2030 (USD Million)
Fig. 50 Medical foods market estimates and forecasts for wound healing, 2018 - 2030 (USD Million)
Fig. 51 Medical foods market estimates and forecasts for chronic diarrhea, 2018 - 2030 (USD Million)
Fig. 52 Medical foods market estimates and forecasts for constipation relief, 2018 - 2030 (USD Million)
Fig. 53 Medical foods market estimates and forecasts for protein booster, 2018 - 2030 (USD Million)
Fig. 54 Medical foods market estimates and forecasts for dysphagia, 2018 - 2030 (USD Million)
Fig. 55 Medical foods market estimates and forecasts for pain management, 2018 - 2030 (USD Million)
Fig. 56 Medical foods market estimates and forecasts for Parkinson's disease, 2018 - 2030 (USD Million)
Fig. 57 Medical foods market estimates and forecasts for epilepsy, 2018 - 2030 (USD Million)
Fig. 58 Medical foods market estimates and forecasts for cancer, 2018 - 2030 (USD Million)
Fig. 59 Medical foods market estimates and forecasts for Cachexia , 2018 - 2030 (USD Million)
Fig. 60 Medical foods market estimates and forecasts for severe protein allergy, 2018 - 2030 (USD Million)
Fig. 61 Medical foods market estimates and forecasts for other diseases, 2018 - 2030 (USD Million)
Fig. 62 Medical foods market, sales channel outlook: Key takeaways, USD Million
Fig. 63 Medical foods market: Sales channel movement analysis, 2023 & 2030 (USD Million)
Fig. 64 Medical foods market estimates and forecasts for online sales channel, 2018 - 2030 (USD Million)
Fig. 65 Medical foods market estimates and forecasts for retail sales channel, 2018 - 2030 (USD Million)
Fig. 66 Medical foods market estimates and forecasts for institutional sales channel, 2018 - 2030 (USD Million)
Fig. 67 Regional marketplace: Key takeaways
Fig. 68 Medical foods market: Regional movement analysis, 2023 & 2030 (USD Million)
Fig. 69 North America medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 U.S country dynamics
Fig. 71 U.S. medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Canada country dynamics
Fig. 73 Canada medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Europe medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 UK country dynamics
Fig. 76 UK medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Germany country dynamics
Fig. 78 Germany medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 France country dynamics
Fig. 80 France medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Spain country dynamics
Fig. 82 Spain medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Italy country dynamics
Fig. 84 Italy medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Sweden country dynamics
Fig. 86 Sweden medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Denmark country dynamics
Fig. 88 Denmark medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Norway country dynamics
Fig. 90 Norway medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Asia Pacific medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Japan country dynamics
Fig. 93 Japan medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 China country dynamics
Fig. 95 China medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Australia country dynamics
Fig. 97 Australia medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 India country dynamics
Fig. 99 India medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 South Korea country dynamics
Fig. 101 South Korea medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Latin America medical foods market estimates and forecasts, 2018 - 2030 (USD Million
Fig. 103 Brazil country dynamics
Fig. 104 Brazil medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Mexico country d
Fig. 106 Mexico medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Argentina country dynamics
Fig. 108 Argentina medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 MEA medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 South Africa country dynamics
Fig. 111 South Africa medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Saudi Arabia country dynamics
Fig. 113 Saudi Arabia medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 UAE country dynamics
Fig. 115 UAE medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 116 Kuwait country dynamics
Fig. 117 Kuwait medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Qatar: Country Dynamics
Fig. 119 Qatar medical foods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Key company categorization
Fig. 121 Medical foods company market share analysis, 2023
Fig. 122 Company market position analysis
Fig. 123 Company market ranking, by region based on number of countries served in each region
Fig. 124 Abbott: Key Insights
Fig. 125 Abbott: Key Insights
Fig. 126 Nestle: Key Insights
Fig. 127 Nestle: Key Insights
Fig. 128 Danone: Key Insights
Fig. 129 Danone: Key Insights
Fig. 130 Sales Revenue By Online Sales Channel And Retail Sales Channel For Key Companies

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Medical Foods Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
    • Oral
    • Enteral
  • Medical Foods Product Outlook (Revenue, USD Billion, 2018 - 2030)
    • Powder
    • Pills
    • Liquid
    • Other
  • Medical Foods Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Chronic Kidney Disease
    • Minimal Hepatic Encephalopathy
    • Chemotherapy Induced Diarrhea
    • Pathogen Related Infections
    • Diabetic Neuropathy
    • ADHD
    • Depression
    • Alzheimer's Disease
    • Nutritional Deficiency
    • Orphan Diseases
      • Tyrosinemia
      • Eosinophilic Esophagitis
      • FPIES
      • Phenylketonuria
      • MSUD
      • Homocystinuria
      • Others
    • Wound Healing
    • Chronic Diarrhea
    • Constipation Relief
    • Protein Booster
    • Dysphagia
    • Pain Management
    • Parkinson's Disease
    • Epilepsy
    • Other Cancer related treatments
    • Severe Protein Allergy
    • Cancer
    • Cachexia
    • Other
  • Medical Foods Sales Channel Outlook (Revenue, USD Billion, 2018 - 2030)
    • Online Sales
    • Retail Sales
    • Institutional Sales
  • Medical Foods Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Medical Foods Market, By Route of Administration
        • Oral
        • Enteral
      • North America Medical Foods Market, By Product
        • Powder
        • Pills
        • Liquid
        • Other
      • North America Medical Foods Market, By Application
        • Chronic Kidney Disease
        • Minimal Hepatic Encephalopathy
        • Chemotherapy Induced Diarrhea
        • Pathogen Related Infections
        • Diabetic Neuropathy
        • ADHD
        • Depression
        • Alzheimer's Disease
        • Nutritional Deficiency
        • Orphan Diseases
          • Tyrosinemia
          • Eosinophilic Esophagitis
          • FPIES
          • Phenylketonuria
          • MSUD
          • Homocystinuria
          • Others
        • Wound Healing
        • Chronic Diarrhea
        • Constipation Relief
        • Protein Booster
        • Dysphagia
        • Pain Management
        • Parkinson's Disease
        • Epilepsy
        • Other Cancer related treatments
        • Severe Protein Allergy
        • Cancer
        • Cachexia
        • Other
      • North America Medical Foods Market, By Sales Channel
        • Online Sales
        • Retail Sales
        • Institutional Sales
      • U.S.
        • U.S. Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • U.S. Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • U.S. Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • U.S. Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Canada
        • Canada Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Canada Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Canada Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Canada Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
    • Europe
      • Europe Medical Foods Market, By Route of Administration
        • Oral
        • Enteral
      • Europe Medical Foods Market, By Product
        • Powder
        • Pills
        • Liquid
        • Other
      • Europe Medical Foods Market, By Application
        • Chronic Kidney Disease
        • Minimal Hepatic Encephalopathy
        • Chemotherapy Induced Diarrhea
        • Pathogen Related Infections
        • Diabetic Neuropathy
        • ADHD
        • Depression
        • Alzheimer's Disease
        • Nutritional Deficiency
        • Orphan Diseases
          • Tyrosinemia
          • Eosinophilic Esophagitis
          • FPIES
          • Phenylketonuria
          • MSUD
          • Homocystinuria
          • Others
        • Wound Healing
        • Chronic Diarrhea
        • Constipation Relief
        • Protein Booster
        • Dysphagia
        • Pain Management
        • Parkinson's Disease
        • Epilepsy
        • Other Cancer related treatments
        • Severe Protein Allergy
        • Cancer
        • Cachexia
        • Other
      • Europe Medical Foods Market, By Sales Channel
        • Online Sales
        • Retail Sales
        • Institutional Sales
      • Germany
        • Germany Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Germany Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Germany Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Germany Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • UK
        • UK Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • UK Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • UK Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • UK Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • France
        • France Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • France Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • France Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • France Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Italy
        • Italy Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Italy Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Italy Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Italy Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Spain
        • Spain Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Spain Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Spain Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Spain Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Sweden
        • Sweden Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Sweden Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Sweden Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Sweden Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Denmark
        • Denmark Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Denmark Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Denmark Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Denmark Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Norway
        • Norway Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Norway Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Norway Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Norway Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
    • Asia Pacific
      • Asia Pacific Medical Foods Market, By Route of Administration
        • Oral
        • Enteral
      • Asia Pacific Medical Foods Market, By Product
        • Powder
        • Pills
        • Liquid
        • Other
      • Asia Pacific Medical Foods Market, By Application
        • Chronic Kidney Disease
        • Minimal Hepatic Encephalopathy
        • Chemotherapy Induced Diarrhea
        • Pathogen Related Infections
        • Diabetic Neuropathy
        • ADHD
        • Depression
        • Alzheimer's Disease
        • Nutritional Deficiency
        • Orphan Diseases
          • Tyrosinemia
          • Eosinophilic Esophagitis
          • FPIES
          • Phenylketonuria
          • MSUD
          • Homocystinuria
          • Others
        • Wound Healing
        • Chronic Diarrhea
        • Constipation Relief
        • Protein Booster
        • Dysphagia
        • Pain Management
        • Parkinson's Disease
        • Epilepsy
        • Other Cancer related treatments
        • Severe Protein Allergy
        • Cancer
        • Cachexia
        • Other
      • Asia Pacific Medical Foods Market, By Sales Channel
        • Online Sales
        • Retail Sales
        • Institutional Sales
      • China
        • China Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • China Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • China Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • China Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Japan
        • Japan Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Japan Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Japan Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Japan Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • India
        • India Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • India Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • India Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • India Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • South Korea
        • South Korea Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • South Korea Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • South Korea Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • South Korea Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Australia
        • Australia Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Australia Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Australia Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Australia Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
    • Latin America
      • Latin America Medical Foods Market, By Route of Administration
        • Oral
        • Enteral
      • Latin America Medical Foods Market, By Product
        • Powder
        • Pills
        • Liquid
        • Other
      • Latin America Medical Foods Market, By Application
        • Chronic Kidney Disease
        • Minimal Hepatic Encephalopathy
        • Chemotherapy Induced Diarrhea
        • Pathogen Related Infections
        • Diabetic Neuropathy
        • ADHD
        • Depression
        • Alzheimer's Disease
        • Nutritional Deficiency
        • Orphan Diseases
          • Tyrosinemia
          • Eosinophilic Esophagitis
          • FPIES
          • Phenylketonuria
          • MSUD
          • Homocystinuria
          • Others
        • Wound Healing
        • Chronic Diarrhea
        • Constipation Relief
        • Protein Booster
        • Dysphagia
        • Pain Management
        • Parkinson's Disease
        • Epilepsy
        • Other Cancer related treatments
        • Severe Protein Allergy
        • Cancer
        • Cachexia
        • Other
      • Latin America Medical Foods Market, By Sales Channel
        • Online Sales
        • Retail Sales
        • Institutional Sales
      • Brazil
        • Brazil Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Brazil Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Brazil Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Brazil Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Mexico
        • Mexico Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Mexico Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Mexico Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Mexico Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Argentina
        • Argentina Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Argentina Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Argentina Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Argentina Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
    • Middle East and Africa (MEA)
      • Middle East and Africa (MEA) Medical Foods Market, By Route of Administration
        • Oral
        • Enteral
      • Middle East and Africa (MEA) Medical Foods Market, By Product
        • Powder
        • Pills
        • Liquid
        • Other
      • Middle East and Africa (MEA) Medical Foods Market, By Application
        • Chronic Kidney Disease
        • Minimal Hepatic Encephalopathy
        • Chemotherapy Induced Diarrhea
        • Pathogen Related Infections
        • Diabetic Neuropathy
        • ADHD
        • Depression
        • Alzheimer's Disease
        • Nutritional Deficiency
        • Orphan Diseases
          • Tyrosinemia
          • Eosinophilic Esophagitis
          • FPIES
          • Phenylketonuria
          • MSUD
          • Homocystinuria
          • Others
        • Wound Healing
        • Chronic Diarrhea
        • Constipation Relief
        • Protein Booster
        • Dysphagia
        • Pain Management
        • Parkinson's Disease
        • Epilepsy
        • Other Cancer related treatments
        • Severe Protein Allergy
        • Cancer
        • Cachexia
        • Other
      • Middle East and Africa (MEA) Medical Foods Market, By Sales Channel
        • Online Sales
        • Retail Sales
        • Institutional Sales
      • Saudi Arabia
        • Saudi Arabia Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Saudi Arabia Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Saudi Arabia Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Saudi Arabia Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • UAE
        • UAE Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • UAE Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • UAE Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • UAE Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • South Africa
        • South Africa Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • South Africa Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • South Africa Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • South Africa Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Kuwait
        • Kuwait Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Kuwait Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Kuwait Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Kuwait Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales
      • Qatar
        • Qatar Medical Foods Market, By Route of Administration
          • Oral
          • Enteral
        • Qatar Medical Foods Market, By Product
          • Powder
          • Pills
          • Liquid
          • Other
        • Qatar Medical Foods Market, By Application
          • Chronic Kidney Disease
          • Minimal Hepatic Encephalopathy
          • Chemotherapy Induced Diarrhea
          • Pathogen Related Infections
          • Diabetic Neuropathy
          • ADHD
          • Depression
          • Alzheimer's Disease
          • Nutritional Deficiency
          • Orphan Diseases
            • Tyrosinemia
            • Eosinophilic Esophagitis
            • FPIES
            • Phenylketonuria
            • MSUD
            • Homocystinuria
            • Others
          • Wound Healing
          • Chronic Diarrhea
          • Constipation Relief
          • Protein Booster
          • Dysphagia
          • Pain Management
          • Parkinson's Disease
          • Epilepsy
          • Other Cancer related treatments
          • Severe Protein Allergy
          • Cancer
          • Cachexia
          • Other
        • Qatar Medical Foods Market, By Sales Channel
          • Online Sales
          • Retail Sales
          • Institutional Sales

Medical Foods Market Dynamics

Driver: Rising geriatric population

According to several NCBI studies, individuals over 65 years of age are at a greater risk of developing chronic illnesses such as Parkinson’s disease and nervous system disorders. According to the U.S. Census Bureau, currently, more than 54 million adults in the U.S. are aged 65 and above. This number is expected to reach around 85.7 million by 2050. This is a significant increase from 1950 when the geriatric population was around 8%. The number of elderly patients with critical illnesses has increased significantly in the past few years. The risk of malnutrition and frailty among elderly people with comorbidities, such as stroke, depression, and dementia, is higher owing to various age-related changes in body composition and muscle mass. This results in reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of fall or injuries. Hence, it is important to analyze the pathophysiology behind the nutritional deficiency. According to an NCBI article published in 2018, the prevalence of nutrient deficiency in geriatric population is nearly 15% in ambulatory outpatients, 35% to 65% among hospitalized patients, and 20% to 60% in institutionalized patients. Thus, healthcare professionals focus on maximizing options for enteral nutrition, which is expected to boost the market’s growth.

Driver: Growing prevalence of chronic diseases

Chronic diseases, including non-communicable diseases such as cardiovascular disease, cancer & diabetes, are the leading cause of deaths worldwide. As per the World Health Organization (WHO), non-communicable diseases are responsible for 41 million deaths every year. There has also been a constant rise in the prevalence of other chronic diseases, such as Alzheimer's disease, attention-deficit/hyperactivity disorder (ADHD), osteoporosis, osteoarthritis, and central nervous system disorders. Alzheimer’s disease is one of the common neurodegenerative medical conditions that leads to dementia, decline in functional ability, and behavioral changes along with economic burden. According to the Alzheimer’s Association, as of 2022, approximately 6.5 million people in the U.S. aged 65 and above are living with Alzheimer’s dementia. Moreover, 10% of the world’s population aged 60 and above has osteoarthritis-related health problems. All these chronic conditions require clinical dietary management, which is anticipated to contribute to driving the growth of the market.

Restraint: Lack of awareness in the medical community

The general lack of awareness and understanding regarding medical foods in the medical community is restricting the adoption of medical foods. These foods require prescription and supervision by medical professionals. Although they are gaining acceptance, medical foods remain poorly understood by patients, physicians, and pharmacists. This factor prevents doctors from adopting or prescribing medical foods, which may restrain market growth. Not all medical experts are convinced about the advantages of medical foods in chronic disease management, which is expected to impede market growth. The management of chronic diseases is majorly based on drug-based therapies. With the introduction of medical foods, drug-based therapies are supplemented with foods for special medical purposes. However, limited adoption of these products in some countries is restraining the growth. Some health services and payers do not cover the cost of medical foods in disease management, which can also hinder the growth. However, manufacturers are focusing on raising awareness among consumer and healthcare professionals, which is anticipated to help change market dynamics.

What Does This Report Include?

This section will provide insights into the contents included in this medical foods market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Medical foods market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Medical foods market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the medical foods market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for medical foods market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of medical foods market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Medical Foods Market Categorization:

The medical foods market was categorized into five segments, namely route of administration (Oral, Enteral), product (Powder, Pills, Liquid), application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Other Cancer related treatments, Severe Protein Allergy, Cancer, Cachexia), sales channel (Online Sales, Retail Sales, Institutional Sales), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The medical foods market was segmented into route of administration, product, application, sales channel, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The medical foods market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S., Canada, Germany, the UK., France, Italy, Spain, Sweden, Denmark, Norway, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, Kuwait, Qatar and South Africa.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Medical foods market companies & financials:

The medical foods market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Danone S.A.: Danone S.A. is one of the leading global food companies. It runs through four business segments, namely, early life nutrition, waters, fresh dairy products, and advanced medical nutrition. The company has a presence in more than 120 countries. Nutricia Advanced Medical Nutrition is a part of Danone Food Company that deals with nutritional solutions for diseased and aging population. The company’s offerings range across various conditions such as cancer, diabetes, lactose intolerance, metabolic disorders, and dysphagia. China, Turkey, and Latin America are some of the biggest markets for the company. Neocate Splash, Nutrini, and Nutrison are the company’s the top three medical nutrition brands.

  • Nestlé S.A.: Nestlé S.A. is a leading nutrition, wellness, and healthcare brand founded 150 years ago. The company started as a condensed milk manufacturer and diversified into infant cereal, nutritional formulas, healthcare nutrition, weight management solutions, and food & beverages. The company boasts of more than 2,000 well-established brands and has manufacturing facilities across 85 countries. It sells and markets health foods under the brand name Nestlé Health Science, formed in 2011. Medical Nutrition is Nestlé Health Science’s largest business and one of its key focus areas is acute care with a wide range of nutritional solutions for critically ill and older people suffering from disease-related malnutrition.

  • Abbott: Abbott is a biotechnology company involved in the worldwide development of in vitro diagnostic instrument systems and tests for hospitals, physician offices, reference laboratories, clinics, & blood banks. It offers hematology, automation, and transfusion instruments and immunochemistry reagents & tests for applications in the fields of cancer & cardiology, drugs of abuse, fertility, infectious diseases, retrovirus, therapeutic drug monitoring, and transplant. Its portfolio offerings are focused on the fields such as medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals. The company has sales in more than 150 countries.

  • Targeted Medical Pharma Inc.: Targeted Medical Pharma Inc. is a specialty pharmaceutical company that is dedicated to developing amino acid-based medications. The company is currently involved in developing patented amino acid-based medical foods, dietary supplements, and generic drugs to be distributed to physicians, patients, and pharmacies worldwide. It owns manufacturing facilities in the U.S. and is involved in selling its products in the U.S., Japan, Ukraine, China, Russia, and New Zealand among other countries. It partnered with various organizations in countries such as Ukraine, Hong Kong, Japan, Russia, and New Zealand for the development and distribution of products with patented core ingredient technology. It distributes its products through an internal sales staff and independent distributors across the U.S.

  • Primus Pharmaceuticals, Inc.: Primus Pharmaceuticals, Inc. is a privately held company, involved in the manufacturing and selling of prescription medical food products. The company’s target customers include physicians in the fields such as rheumatology, pain management, orthopedics, gynecology, and dermatology. Its product portfolio caters to atopic dermatitis, osteoporosis/osteopenia, rheumatoid arthritis, and chronic venous disease, among others. Some of its popular brands include EpiCeram, Fosteum PLUS, Rheumate, and Vasculera. The company promotes its products to physicians through salesforce and co-promotion partnerships with other pharmaceutical organizations.

  • Mead Johnson & Company, LLC: Mead Johnson & Company, LLC is engaged in manufacturing and marketing of products focused primarily on infant and child nutrition. In 2017, following the acquisition, the company became a wholly owned subsidiary of Reckitt Benckiser Group plc. The company runs through two major business segments, namely, Infant Formula and Children’s Nutrition. Their Enfa product line is one of the leading global infant nutrition brands. The company has around 70 products in over 50 countries, including China, Thailand, Malaysia, Indonesia, Vietnam, and, recently, India.

  • Medtrition Inc.: Medtrition Inc. is a privately held company, formerly known as American Institutional Products Company of PA. It specializes in medical foods and has a presence in the medical foods industry for more than 30 years. The company’s instant food thickeners have revolutionized the dysphagia market. The company deals with medical foods for bowel management, oncology care, renal and liver disease, urinary tract infections, wound care, thickened dairy, protein & calorie malnutrition, and dysphagia. It serves more than 1,500 acute care facilities in more than 35 countries. Various healthcare professionals such as dieticians, nutritionists, and clinicians use this company’s products. They are also used in hospitals, wound care clinics, oncology centers, and dialysis centers.

  • Fresenius Kabi AG: Fresenius Kabi AG is a subsidiary of Fresenius SE & Co. KGaA, a global healthcare group. Fresenius SE & Co. KGaA has independent business segments, including Fresenius Kabi, Fresenius Vamed, Fresenius Medical Care, and Fresenius Helios. It has presence in over 100 countries. Fresenius Kabi AG operates in various segments, including biosimilar, intravenous (IV) drugs, clinical nutrition, medical devices/transfusion technology, and infusion therapy. The company is involved in supplying transfusion technology products and medical devices. Its clinical nutrition segment includes products focusing on enteral nutrition, parenteral nutrition, and infusion disposables.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Medical Foods Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Medical Foods Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.